⚡Glenmark to Start New Phase 3 Clinical Trial for Hospitalised Patients of Moderate COVID-19
By ANI
Glenmark Pharmaceuticals on Tuesday announced a new randomised, open-label study to test the combined efficacy of two antiviral drugs Favipiravir and Umifenovir as a potential COVID-19 treatment strategy.